Sfoglia per Rivista
Safety and efficacy of low-dose subcuteneous campath-1H therapy in patients with refractory chronic lymphocytic leukaemia
2005 A. Cortelezzi, M.C. Pasquini, N.N. Fantini, V.R. Zilioli, M. Colombi, B. Sarina, G. Lambertenghi Deliliers
The safety profile of deferasirox remains consistent as non-transfusion-dependent thalassemia patients approach the target liver iron concentration of <3 mg FE/G DW for interrupting chelation
2013 A. Taher, J. Porter, V. Viprakasit, A. Kattamis, S. Chuncharunee, P. Sutcharitchan, N. Siritanaratkul, R. Galanello, Z. Karakas, D. Habr, Z. Zhu, M. Cappellini
SDF1-3'A gene polymorphism : risk factor for thrombotic events in Philadelphia-negative chronic myeloproliferative disorders
2005 C. Vanelli, M.L. Biondi, O. Turri, A. La Torre, A. Gardellini, M. Pugliano, L. Battaglioli, M. Erario, G. Gerli
SDF1-3A polymorphism in myelofibrosis with myeloid metaplasia : genotype-phenotype correlation
2006 M. Marchetti, M.L. Biondi, M. Massa, R. Campanelli, G. Bergamaschi, E. Bonetti, V. Rosti, A. Pecci, G. Gerli, G. Barosi
Second malignancies in essential thrombocytosis : a retrospective analysis of 331 patients from a single institution
2005 F. Radaelli, F.G. Rossi, F. Onida, M.C. Pasquini, P. Usardi, R. Calori, A. Zanella
Second malignancies in essential thrombocytosis: a retrospective analysis of 331 patients from a single institution (Abs. P351)
2005 F. Radaelli, S. Bramanti, R. Calori, F. Onida, M. Colombi, P. Usardi, P. Faccini, A. Zanella
SECOND PRIMARY MALIGNANCY IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB
2019 N. Polverelli, E. Elli, E. Abruzzese, G.A. Palumbo, G. Benevolo, M. Breccia, M. Tiribelli, M. Bonifacio, A. Tieghi, B. Martino, N. Sgherza, M. D’Adda, M. Bergamaschi, M. Crugnola, F. Cavazzini, C. Bosi, G. Binotto, A. Isidori, D. Bartoletti, G. Auteri, R. Latagliata, L. Gandolfi, L. Scaffidi, D. Cattaneo, K. Codeluppi, M. Trawinska, D. Griguolo, A. Cuneo, M. Krampera, G. Semenzato, F. Di Raimondo, R.M. Lemoli, M. Cavo, N. Vianelli, D. Russo, A. Iurlo, F. Palandri
Secondary malignancies in chronic lymphocytic leukemia: a single centre retrospective analysis
2016 G. Reda, B. Fattizzo, R. Cassin, N. Orofino, E. Flospergher, D. Consonni, W. Barcellini, A. Cortelezzi
Self-testing and self-monitoring of oral anticoagulant therapy: consensus of the Italian Federation of Anticoagulation Clinics
2003 V. Pengo, G. Finazzi, S. Testa, A. Tripodi
Septicemia in hematologic malignancies : statistical analysis of prognostic factors
1985 A. Cortelezzi, F. Radaelli, R. Mozzana, B.M. Cesana, L. Baldini, E.E. Polli
Seronegative antiphospholipid syndrome: Refining the value of “non-criteria” antibodies for diagnosis and clinical management
2020 P. Pignatelli, E. Ettorre, D. Menichelli, A. Pani, F. Violi, D. Pastori
Serum and cellular expression of thrombopoietin in early B-cell chronic lymphocytic leukemia in comparison with immunoglobulin heavy-chain mutation status
2007 S. Molica, G. Vitelli, G. Cutrona, K. Todoerti, R. Mirabelli, G. Digiesi, F. Morabito, A. Neri, M. Ferrarini
SERUM FERRITIN FOR PREDICTING CLINICALLY RELEVANT LIC THRESHOLDS TO GUIDE MANAGEMENT OF PATIENTS WITH NONTRANSFUSION-DEPENDENT THALASSEMIA TREATED WITH DEFERASIROX: THALASSA STUDY EXTENSION ANALYSIS
2013 A. Taher, J. Porter, V. Viprakasit, A. Kattamis, S. Chuncharunee, P. Sutcharitchan, N. Siritanaratkul, R. Galanello, Z. Karakas, D. Habr, Z. Zhu, M. Cappellini
Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: The orient study
2014 K.M. Musallam, M.D. Cappellini, S. Daar, M. Karimi, A. El Beshlawy, G. Graziadei, M. Magestro, J. Wulff, G. Pietri, A.T. Taher
Serum levels of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia (CLL)
2009 S. Molica, G. Digiesi, R. Mirabelli, G. Cutrona, A. Antenucci, D. Giannarelli, I. Sperduti, F. Morabito, A. Neri, L. Baldini, M. Ferrarini
Severe bleeding and absent ADP-induced platelet aggregation associated with inherited combined CalDAG-GEFI and P2Y12 deficiencies
2019 B. Lunghi, A. Lecchi, R. Santacroce, M. Scavone, R. Paniccia, A. Artoni, C. Gachet, G. Castaman, M. Margaglione, F. Bernardi, M. Cattaneo
Severe factor XI deficiency in the Abruzzo region of Italy is associated to different FXI gene mutations
2008 G. Castaman, S.H. Giacomelli, A. Dragani, O. Iuliani, S. Duga, F. Rodeghiero
Short-course imatinib (IM) added to chemotherapy improves early but not long-term outcome in adult Ph/BCR-ABL+ acute lymphoblastic leukemia (ALL) : 5-year follow-up results of study NILG-09
2008 R. Bassan, T. Intermesoli, E. Oldani, G. Rossi, E. Borlenghi, E.M. Pogliani, E. Terruzzi, P. Fabris, E. Di Bona, G. Gianfaldoni, C. Romani, A. Cortelezzi, D. Mattei, O. Spinelli, A. Rambaldi
Sickle cell disease and sickle beta-thalassemia : clinical features
2011 G. Graziadei, M. Soldarini, C. Cesaretti, C. Refaldi, M. Salvatori, E. Cassinerio, M.D. Cappellini
Significant global hypomethylationmof DNA repetitive sequences in cell chronic lymphocitic patients with 17P deletion
2010 S. Fabris, V. Bollati, L. Agnelli, F. Morabito, V. Motta, G. Cutrona, S. Matis, V. Gigliotti, M. Gentile, M. Zappa, G. Lambertenghi Deliliers, P.A. Bertazzi, M. Ferrarini, A. Baccarelli, A. Neri
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile